Biliary Atresia, Liver Diseases, Liver Transplantation, Morbidity;Infant, Mortality
Conditions
Brief summary
The Department of Organ Transplantation in Memorial Hospitals has started Pediatric Liver Transplantation Program in 2016. As of the end of 2020, we have performed 169 pediatric liver transplantation. The aim of this study is to investigate the overall mortality, morbidity and risk factors for adverse outcomes in pediatric liver transplantation. The patients' records will be retrospectively scanned and the data will be gathered.
Interventions
PROCEDURELiver Transplantation
Liver Transplantation is performed under spesific conditions to increase the life time of patients with liver diseases.
Sponsors
Memorial Bahçelievler Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
0 Months to 18 Years
Healthy volunteers
No
Inclusion criteria
* Pediatric patients with liver transplantation (\<18 years)
Exclusion criteria
* Patients with incomplete medical records will be excluded
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Survival | 1 minutes | Patient and graft survival ratios |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Perioperative informations | 5 minutes | Perioperative informations such as blood loss and blood transfusion |
| Blood Tests | 15 minutes | Blood markers that evaluated at the pre and post operative phase such as Internation Normalized Ratio (INR), total bilirubin and albumin values. |
| Postoperative Complications | 5 minutes | Postoperative Complications such as sepsis or hepatic artery thrombosis |
| Postoperative informations | 10 minutes | Postoperative informations such as initial hospital stay, ICU stay or mechanic ventilation time |
Countries
Turkey (Türkiye)
Outcome results
None listed